News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
648,418 Results
Type
Article (52333)
Company Profile (130)
Press Release (595945)
Multimedia
Podcasts (110)
Webinars (17)
Section
Business (175333)
Career Advice (2755)
Deals (32843)
Drug Delivery (132)
Drug Development (80143)
Employer Resources (163)
FDA (15368)
Job Trends (13955)
News (312486)
Policy (33269)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2803)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (145)
Alliances (50782)
ALS (178)
Alzheimer's disease (1758)
Antibody-drug conjugate (ADC) (332)
Approvals (15555)
Artificial intelligence (539)
Autoimmune disease (167)
Automation (37)
Bankruptcy (346)
Best Places to Work (11123)
BIOSECURE Act (22)
Biosimilars (192)
Biotechnology (88)
Bladder cancer (156)
Brain cancer (63)
Breast cancer (648)
Cancer (4899)
Cardiovascular disease (421)
Career advice (2332)
Career pathing (41)
CAR-T (298)
CDC (57)
Cell therapy (774)
Cervical cancer (34)
Clinical research (68225)
Collaboration (1772)
Company closure (4)
Compensation (1079)
Complete response letters (71)
COVID-19 (2929)
CRISPR (98)
C-suite (893)
Cystic fibrosis (136)
Data (6196)
Decentralized trials (2)
Denatured (21)
Depression (149)
Diabetes (516)
Diagnostics (6474)
Digital health (43)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (257)
Drug pricing (206)
Drug shortages (33)
Duchenne muscular dystrophy (240)
Earnings (63278)
Editorial (66)
Employer branding (22)
Employer resources (152)
Events (89248)
Executive appointments (1006)
FDA (18414)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (22)
Funding (1423)
Gene editing (203)
Generative AI (47)
Gene therapy (643)
GLP-1 (1098)
Government (5087)
Grass and pollen (7)
Guidances (383)
Healthcare (18058)
HIV (64)
Huntington's disease (50)
IgA nephropathy (85)
Immunology and inflammation (286)
Immuno-oncology (62)
Indications (108)
Infectious disease (3224)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (123)
Intellectual property (250)
Interviews (555)
IPO (14749)
IRA (55)
Job creations (3154)
Job search strategy (1901)
JPM (63)
Kidney cancer (18)
Labor market (75)
Layoffs (591)
Leadership (38)
Legal (8453)
Liver cancer (97)
Longevity (14)
Lung cancer (677)
Lymphoma (372)
Machine learning (40)
Management (57)
Manufacturing (795)
MASH (179)
Medical device (12012)
Medtech (12060)
Mergers & acquisitions (19141)
Metabolic disorders (1370)
Multiple sclerosis (168)
NASH (23)
Neurodegenerative disease (348)
Neuropsychiatric disorders (96)
Neuroscience (3055)
Neurotech (1)
NextGen: Class of 2026 (6330)
Non-profit (4543)
Now hiring (59)
Obesity (668)
Opinion (315)
Ovarian cancer (165)
Pain (208)
Pancreatic cancer (230)
Parkinson's disease (287)
Partnered (35)
Patents (500)
Patient recruitment (495)
Peanut (57)
People (55918)
Pharmaceutical (32)
Pharmacy benefit managers (25)
Phase 1 (21101)
Phase 2 (29925)
Phase 3 (22665)
Pipeline (5294)
Policy (315)
Postmarket research (2655)
Preclinical (8917)
Press Release (63)
Prostate cancer (240)
Psychedelics (57)
Radiopharmaceuticals (286)
Rare diseases (890)
Real estate (4953)
Recruiting (71)
Regulatory (24311)
Reports (38)
Research institute (2448)
Resumes & cover letters (417)
Rett syndrome (28)
RNA editing (17)
RSV (83)
Schizophrenia (158)
Series A (231)
Series B (185)
Service/supplier (5)
Sickle cell disease (103)
Special edition (20)
Spinal muscular atrophy (168)
Sponsored (41)
Startups (3223)
State (2)
Stomach cancer (20)
Supply chain (104)
Tariffs (88)
The Weekly (88)
Vaccines (1142)
Venture capital (90)
Weight loss (455)
Women's health (78)
Worklife (22)
Date
Today (120)
Last 7 days (506)
Last 30 days (2037)
Last 365 days (28492)
2026 (3401)
2025 (28783)
2024 (33185)
2023 (37383)
2022 (48332)
2021 (52286)
2020 (51133)
2019 (44664)
2018 (33864)
2017 (30816)
2016 (29553)
2015 (34153)
2014 (26539)
2013 (22191)
2012 (23691)
2011 (24547)
2010 (22369)
Location
Africa (900)
Alabama (79)
Alaska (5)
Arizona (243)
Arkansas (12)
Asia (40290)
Australia (7793)
California (10161)
Canada (3130)
China (1124)
Colorado (431)
Connecticut (436)
Delaware (328)
Europe (93273)
Florida (1605)
Georgia (324)
Hawaii (4)
Idaho (59)
Illinois (812)
India (68)
Indiana (479)
Iowa (19)
Japan (427)
Kansas (120)
Kentucky (36)
Louisiana (27)
Maine (61)
Maryland (1318)
Massachusetts (7230)
Michigan (299)
Minnesota (508)
Mississippi (5)
Missouri (127)
Montana (30)
Nebraska (24)
Nevada (116)
New Hampshire (78)
New Jersey (2824)
New Mexico (24)
New York (2738)
North Carolina (1308)
North Dakota (7)
Northern California (4948)
Ohio (291)
Oklahoma (16)
Oregon (33)
Pennsylvania (2083)
Puerto Rico (24)
Rhode Island (38)
South America (1230)
South Carolina (66)
South Dakota (1)
Southern California (4011)
Tennessee (158)
Texas (1620)
United States (36464)
Utah (324)
Vermont (1)
Virginia (259)
Washington D.C. (72)
Washington State (846)
West Virginia (4)
Wisconsin (95)
Wyoming (2)
648,418 Results for "covestro formerly known as bayer materialscience ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
November 7, 2025
·
4 min read
Press Releases
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo
February 5, 2026
·
8 min read
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
January 28, 2026
·
4 min read
Press Releases
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
December 2, 2025
·
4 min read
Press Releases
Bayer Accelerates Pharma Growth on High-Value Portfolio
January 14, 2026
·
13 min read
Press Releases
Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
November 24, 2025
·
6 min read
Press Releases
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
January 20, 2026
·
4 min read
Press Releases
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
January 7, 2026
·
4 min read
Press Releases
RSNA25: Pediatric Study for Bayer’s Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
December 4, 2025
·
6 min read
1 of 64,842
Next
